GlaxoSmithKline (Netherlands)
In research, GlaxoSmithKline (Netherlands) stands highest in Medicine (#3,804 of 17,978 worldwide), Life Sciences (#3,311 of 14,347 worldwide) and Health Sciences (#5,016 of 20,462 worldwide), over all time.
- World rank, all time
- #5,876 of 42,892
- Rank in Netherlands
- #83 of 464
- Research works
- 533 ▼ 56% vs 2013–17
- Citations
- 35k 66.5 per fractional work
- Top-10% rate
- 6.9% record average 16.5%
- Open access
- 36% world 28%
What is GlaxoSmithKline (Netherlands) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #3,804 of 17,978 | 31.3% | 216 | |
| Life SciencesDomain | #3,311 of 14,347 | 31.0% | 181 | |
| Health SciencesDomain | #5,016 of 20,462 | 30.1% | 238 |
Each strip is that field’s whole ranked pool, with the notch where GlaxoSmithKline (Netherlands) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 5.2×. Every wedge is a field page.
- Mathematics 5.2×
- Immunology and Microbiology 4.8×
- Veterinary 4.8×
- Pharmacology, Toxicology and Pharmaceutics 4.1×
- Biochemistry, Genetics and Molecular Biology 4.0×
- Chemical Engineering 2.2×
- Medicine 2.2×
- Chemistry 1.7×
- Health Professions 0.9×
- Decision Sciences 0.7×
- Neuroscience 0.7×
- Psychology 0.5×
- Computer Science 0.4×
- Nursing 0.3×
- Social Sciences 0.3×
- Economics, Econometrics and Finance 0.3×
- Business, Management and Accounting 0.3×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.2×
- Environmental Science 0.2×
- Materials Science 0.1×
Which keywords describe research at GlaxoSmithKline (Netherlands)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Immune Response, Signal Transduction, Monoclonal Antibodies, Clinical Trials, BRAF gene, MAP Kinase and Biomarkers.
- PARP Inhibitors
- BRCA Mutation
- Treatment
- Multiplexed Assays
- Fc Receptors
- High-Throughput Analysis
- Machine Learning
- Inflammation
- Chemotherapy
- Biomarkers
- Monoclonal Antibodies
- Signal Transduction
- Epidemiology
- Cancer Therapy
- Immune Response
- Clinical Trials
- BRAF gene
- MAP Kinase
- Bayesian Methods
- Therapeutic Antibodies
- Glycosylation
- Antibody Engineering
- Immunotherapy
- Protein Microarrays
- Vaccine
- Breast Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Cancer Therapy3▲ 18×5 topics
- Epidemiology3▲ 2.0×26 topics
- Immune Response2▲ 12×6 topics
- Signal Transduction2▲ 40×2 topics
- Clinical Trials2▲ 8.2×7 topics
- Monoclonal Antibodies2▲ 62×3 topics
- BRAF gene2▲ 316×1 topic
- Biomarkers2▲ 7.5×6 topics
- MAP Kinase2▲ 316×1 topic
- Chemotherapy2▲ 7.1×8 topics
- Bayesian Methods2▲ 90×2 topics
- Inflammation1▲ 2.0×10 topics
- Therapeutic Antibodies1▲ 64×2 topics
- Machine Learning1▲ 1.20×4 topics
- Glycosylation1▲ 32×3 topics
- High-Throughput Analysis1▲ 102×2 topics
- Antibody Engineering1▲ 60×1 topic
- Fc Receptors1▲ 60×1 topic
- Immunotherapy1▲ 4.6×4 topics
- Multiplexed Assays1▲ 204×1 topic
- Protein Microarrays1▲ 204×1 topic
- Treatment1▲ 2.8×7 topics
- Vaccine1▲ 8.6×7 topics
- BRCA Mutation1▲ 142×1 topic
- Breast Cancer1▲ 13×4 topics
- PARP Inhibitors1▲ 142×1 topic
Which research topics does GlaxoSmithKline (Netherlands) publish most on?
By volume in 2022–2025: Melanoma and MAPK Pathways, Monoclonal and Polyclonal Antibodies Research, Advanced Biosensing Techniques and Applications and PARP inhibition in cancer therapy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Melanoma and MAPK Pathways Molecular Biology 2 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
- 4 PARP inhibition in cancer therapy Oncology 1 works
- 5 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 6 HER2/EGFR in Cancer Research Oncology 1 works
- 7 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 8 Asthma and respiratory diseases Physiology 1 works
- 9 Immune Cell Function and Interaction Immunology 1 works
- 10 Pediatric health and respiratory diseases Emergency Medical Services 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (Netherlands)'s research output changed?
Output in 2018–2022 was 56% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zeist
- Pension Fund for Care and Well-Being
- Achmea (Netherlands)
- Bartiméus
- Nederlandse Obesitas Kliniek
- Royal Dutch Football Association
- Pantarhei Bioscience (Netherlands)
- Zorgverzekeraars Nederland
- Fresenius Kabi (Netherlands)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.